Hypertensive pregnancy complications in women with epilepsy and antiepileptic drugs: a population-based cohort study of first pregnancies in Norway

Abstract

ObjectivesTo estimate the risk of hypertensive pregnancy complications in women with epilepsy, with and without antiepileptic drugs, and assess the risk associated with the four most common antiepileptic drugs.DesignA population-based cohort study using linked data from the Medical Birth Registry of Norway and the Norwegian Prescription Database. Women with epilepsy with and without antiepileptic drugs were compared with women without epilepsy.SettingNorway, 2004–2012.ParticipantsAll first pregnancies of women with epilepsy and women without epilepsy were included.Primary and secondary outcome measuresMain outcome measures were hypertensive pregnancy complications: a compound variable of any hypertensive disorder, gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, early onset pre-eclampsia, eclampsia and HELLP syndrome (haemolysis, elevated liver enzymes, low platelets).ResultsIn total, 1778 pregnancies in women with epilepsy and 221 662 in women without epilepsy were analysed. 682 of the women with epilepsy used antiepileptic drugs, the most common in monotherapy being: lamotrigine (n=280), carbamazepine (n=94), levetiracetam (n=71) and valproate (n=51). There was an increased risk of any hypertensive disorder in women with epilepsy (adjusted OR (aOR) 1.2, 95% CI 1.0 to 1.5) and in the subcategory using valproat (aOR 2.9, 95% CI 1.3 to 6.4). The most frequent hypertensive complication was mild pre-eclampsia and the risk was increased in women with epilepsy (aOR 1.4, 95% CI 1.1 to 1.8) and women with epilepsy with valproat (aOR 3.3, 95% CI 1.2 to 9.4).ConclusionsWomen with epilepsy have an increased risk of mild pre-eclampsia, but not for the severe types of hypertensive pregnancy complications. Lamotrigine and levetiracetam do not predispose for mild pre-eclampsia, whereas valproate was associated with an increased risk of mild pre-eclampsia.

The effect of parity on risk of complications in pregnant women with epilepsy: a population‐based cohort study

“…Only two previous studies have examined first pregnancies separately for hypertensive complications in WWE (2,19). None have examined outcomes in second pregnancies, compared subsequent pregnancies, or assessed recurrence risks.…”

Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort

“…This is in accordance with a recent study on hypertensive pregnancy complications in WWE. [34] Our findings emphasize a need for focused efforts on modifiable risk factors, lifestyle and better health care for WWE to reduce the risk of severe preeclampsia.…”

“…Registration of AED use in MBRN has previously been found to be correct in 91.7% of cases. [33, 34] We identified and analyzed any AED use (all AED use including both mono- and polytherapy treatment). We analyzed also all WWE without any AEDs during their pregnancy.…”

Maternal and fetal outcome of pregnancy complicated by convulsions

“…This is similar to the findings of Bansal et al and International bodies like UK and Ireland registries and Australian registry. 10,11 However, an increased rate of seizure recurrence was noted by Bansal et al during pregnancy in women with epilepsy on levetiracetam. This could be attributed to certain pharmcokinetics like increased renal clearance, increase in volume of distribution etc.…”